GERMANTOWN, MD AND HOUSTON, TX / ACCESS Newswire / December 9, 2025 / uBriGene Biosciences, a global CDMO specializing in ...

RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...

Researchers may have found a way to create synthetic RNA that is more “pure” and cost-effective than previous approaches, expanding opportunities for medicine and therapeutics. According to research ...

A collaborative study by scientists at the University of California, Riverside, and University of Southern California reports ...

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

When a gene is expressed, its DNA sequence is transcribed into a molecule known as RNA. Then the cell processes and edits ...

RNA is a central biological macromolecule, now widely harnessed in medicine and nanotechnology. Like proteins, RNA function ...

A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...

CEATEC 2025 featured the usual lineup of AI demos, service robots, and experimental interfaces. But inside Hall 4, a quieter, lab-style booth ...